These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature]. Etain B; Bonnet-Perrin E Encephale; 2001; 27(3):280-9. PubMed ID: 11488259 [TBL] [Abstract][Full Text] [Related]
7. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647 [TBL] [Abstract][Full Text] [Related]
14. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety. Murphy DL; Pigott TA J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026 [TBL] [Abstract][Full Text] [Related]
15. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. Simeon JG; Thatte S; Wiggins D Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493 [TBL] [Abstract][Full Text] [Related]
17. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder. O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of obsessive-compulsive disorder. Klein DF Encephale; 1990; 16 Spec No():331-4. PubMed ID: 2209491 [TBL] [Abstract][Full Text] [Related]